1134 - Lenzilumab Treatment in COVID-19 Pneumonia Reduces Circulating Cytokines and Markers of Systemic Inflammation

Friday, October 21, 2022

12:15 PM – 1:30 PM US ET

Location: Virtual

Presenting Author(s)

AK

Adrian Kilcoyne, MD

Humanigen Inc.
Short Hills, New Jersey, United States
FC

Frank Cerasoli, PhD

RxMedical Dynamics
New York, New York, United States
JL

John Lukas, PhD

CTI
Covington, Kentucky, United States
CD

Cameron Durrant, MD

Chief Executive Officer
Humanigen, Inc.
Short Hills, New Jersey, United States
Zelalem Temesgen, MD

Professor of Medicine
Mayo Clinic
Rochester, Minnesota, United States
CP

Christopher Polk, MD

Associate Professor
Atrium Health
Charlotte, North Carolina, United States
JB

Jason Baker, MD

Professor
Hennepin Healthcare Research Institute
Minneapolis, Minnesota, United States
VM

Vincent Marconi, MD

Principle Investigator
Emory University
Atlanta, Georgia, United States